Chan P - Search Results

1

The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT. Yau T, et al. Among authors: chan p. Cancer. 2009 Dec 1;115(23):5507-15. doi: 10.1002/cncr.24636. Cancer. 2009. PMID: 19701904 Free article.

2

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.

Yau T, Chan P, Pang R, Ng K, Fan ST, Poon RT. Yau T, et al. Among authors: chan p. Cancer. 2010 Nov 1;116(21):5022-9. doi: 10.1002/cncr.25372. Cancer. 2010. PMID: 20629034 Free article. Clinical Trial.

3

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.

Yau T, Pang R, Chan P, Poon RT. Yau T, et al. Among authors: chan p. Expert Opin Pharmacother. 2010 Sep;11(13):2187-98. doi: 10.1517/14656561003724705. Expert Opin Pharmacother. 2010. PMID: 20707757 Review.

4

Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics.

Yau T, Chen PJ, Chan P, Curtis CM, Murphy PS, Suttle AB, Gauvin J, Hodge JP, Dar MM, Poon RT. Yau T, et al. Among authors: chan p. Clin Cancer Res. 2011 Nov 1;17(21):6914-23. doi: 10.1158/1078-0432.CCR-11-0793. Epub 2011 Aug 10. Clin Cancer Res. 2011. PMID: 21831954 Clinical Trial.

5

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.

Yau T, Yao TJ, Chan P, Wong H, Pang R, Fan ST, Poon RT. Yau T, et al. Among authors: chan p. Oncologist. 2011;16(9):1270-9. doi: 10.1634/theoncologist.2011-0105. Epub 2011 Sep 1. Oncologist. 2011. PMID: 21885876 Free PMC article. Clinical Trial.

6

The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).

Wong H, Tang YF, Yao TJ, Chiu J, Leung R, Chan P, Cheung TT, Chan AC, Pang RW, Poon R, Fan ST, Yau T. Wong H, et al. Among authors: chan p, chan ac. Oncologist. 2011;16(12):1721-8. doi: 10.1634/theoncologist.2011-0192. Epub 2011 Dec 1. Oncologist. 2011. PMID: 22135121 Free PMC article.

7

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease.

Yau T, Wong H, Chan P, Yao TJ, Pang R, Cheung TT, Fan ST, Poon RT. Yau T, et al. Among authors: chan p. Invest New Drugs. 2012 Dec;30(6):2384-90. doi: 10.1007/s10637-012-9808-8. Epub 2012 Mar 9. Invest New Drugs. 2012. PMID: 22402942 Free PMC article. Clinical Trial.

8

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.

Yau T, Cheng PN, Chan P, Chan W, Chen L, Yuen J, Pang R, Fan ST, Poon RT. Yau T, et al. Among authors: chan p, chan w. Invest New Drugs. 2013 Feb;31(1):99-107. doi: 10.1007/s10637-012-9807-9. Epub 2012 Mar 17. Invest New Drugs. 2013. PMID: 22426640 Free PMC article. Clinical Trial.

9

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits.

Chiu J, Tang YF, Yao TJ, Wong A, Wong H, Leung R, Chan P, Cheung TT, Chan AC, Pang R, Fan ST, Poon R, Yau T. Chiu J, et al. Among authors: chan p, chan ac. Cancer. 2012 Nov 1;118(21):5293-301. doi: 10.1002/cncr.27543. Epub 2012 Apr 19. Cancer. 2012. PMID: 22517493 Free article.

10

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.

Yau T, Cheng PN, Chan P, Chen L, Yuen J, Pang R, Fan ST, Wheatley DN, Poon RT. Yau T, et al. Among authors: chan p. Invest New Drugs. 2015 Apr;33(2):496-504. doi: 10.1007/s10637-014-0200-8. Epub 2015 Feb 10. Invest New Drugs. 2015. PMID: 25666409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,490 results

Search Page

Filters